FDA declines to approve Shin Nippon Biomedical's migraine drug

FDA declines to approve Shin Nippon Biomedical's migraine drug

Submitted by admin on January 18, 2024 - 11:05am
Source: 
Reuters
News Tags: 
FDA
Shin Nippon Biomedical
migraines
Headline: 
FDA declines to approve Shin Nippon Biomedical's migraine drug
snippet: 

The U.S. health regulator has declined to approve Japan-based Shin Nippon Biomedical Laboratories' (2395.T) treatment for acute migraine late on Wednesday, citing manufacturing concerns.

Do Not Allow Advertisers to Use My Personal information